Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China

Yang Fei, Jiong Yang, Wei Chung Hsieh, Jeng Yuan Wu, Tzu Chin Wu, Yih Gang Goan, Huei Lee, Ya Wen Cheng

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Inconsistency in the prevalence of infection by human papillomavirus (HPV) in lung cancer patients was found between different countries with racial and geographic variations. Our previous reports have indicated that a high-risk HPV 16/18 DNA was frequently detected in Chinese lung cancer patients living in Taichung, Taiwan (Cheng et al. Cancer Res. 2001;61:2799-803). Thus, we conducted this study to verify whether there was a similar HPV 16/18 infection prevalence in lung cancer patients from Wuhan, China. Methods: To reduce the false positive HPV detection, the paraffin sections of 73 lung tumors and 34 non-cancer controls from Wuhan, China were collected for detection of the presence of HPV 16/18 DNA by in situ hybridization (ISH). Results: Our results showed that the rates of HPV 16 and/or 18 infections in patients with lung tumors were significantly higher than in 34 non-cancer control subjects (26.0 versus 2.8% for HPV 16, P = 0.030; 23.3 versus 5.7% for HPV 18, P = 0.031; 27.7 versus 5.9% for HPV 16 or 18, P = 0.003) with a similar infection frequency of HPV 16 and 18 types in lung tumors. This result indicated that HPV 16/18 infection may be associated with lung cancer development in Chinese patients from Wuhan, China. Further statistical analyses revealed that HPV 16 or 18 infection was not correlated with any clinico-pathological parameter studied, including age, gender, smoking status, tumor type, tumor stage and tumor grades. Interestingly, smoking and male patients had a higher prevalence of HPV 16, although not reaching a statistical significance, compared with non-smoking and female patients, respectively (33.3% for smokers versus 20.0% non-smokers; 33.3% for male versus 17.6% for female). As compared with the HPV 16/18 infection in Taiwan, Chinese patients with lung cancer from Wuhan had a different HPV 16/18 infection prevalence. Conclusion: Difference in HPV 16/18 infection in lung cancer patients from Wuhan, China and Taichung, Taiwan suggests that HPV 16/18 might play a different role in lung cancer development among Chinese living in different areas.

Original languageEnglish
Pages (from-to)274-279
Number of pages6
JournalJapanese Journal of Clinical Oncology
Volume36
Issue number5
DOIs
Publication statusPublished - May 2006
Externally publishedYes

Fingerprint

Human papillomavirus 18
Human papillomavirus 16
Non-Small Cell Lung Carcinoma
China
Infection
Lung Neoplasms
Taiwan
Neoplasms
Lung
Smoking
Papillomavirus Infections
DNA
Paraffin

Keywords

  • Human papillomavirus
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. / Fei, Yang; Yang, Jiong; Hsieh, Wei Chung; Wu, Jeng Yuan; Wu, Tzu Chin; Goan, Yih Gang; Lee, Huei; Cheng, Ya Wen.

In: Japanese Journal of Clinical Oncology, Vol. 36, No. 5, 05.2006, p. 274-279.

Research output: Contribution to journalArticle

Fei, Yang ; Yang, Jiong ; Hsieh, Wei Chung ; Wu, Jeng Yuan ; Wu, Tzu Chin ; Goan, Yih Gang ; Lee, Huei ; Cheng, Ya Wen. / Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. In: Japanese Journal of Clinical Oncology. 2006 ; Vol. 36, No. 5. pp. 274-279.
@article{2dd633d604c545a59127c64eb21d1c11,
title = "Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China",
abstract = "Background: Inconsistency in the prevalence of infection by human papillomavirus (HPV) in lung cancer patients was found between different countries with racial and geographic variations. Our previous reports have indicated that a high-risk HPV 16/18 DNA was frequently detected in Chinese lung cancer patients living in Taichung, Taiwan (Cheng et al. Cancer Res. 2001;61:2799-803). Thus, we conducted this study to verify whether there was a similar HPV 16/18 infection prevalence in lung cancer patients from Wuhan, China. Methods: To reduce the false positive HPV detection, the paraffin sections of 73 lung tumors and 34 non-cancer controls from Wuhan, China were collected for detection of the presence of HPV 16/18 DNA by in situ hybridization (ISH). Results: Our results showed that the rates of HPV 16 and/or 18 infections in patients with lung tumors were significantly higher than in 34 non-cancer control subjects (26.0 versus 2.8{\%} for HPV 16, P = 0.030; 23.3 versus 5.7{\%} for HPV 18, P = 0.031; 27.7 versus 5.9{\%} for HPV 16 or 18, P = 0.003) with a similar infection frequency of HPV 16 and 18 types in lung tumors. This result indicated that HPV 16/18 infection may be associated with lung cancer development in Chinese patients from Wuhan, China. Further statistical analyses revealed that HPV 16 or 18 infection was not correlated with any clinico-pathological parameter studied, including age, gender, smoking status, tumor type, tumor stage and tumor grades. Interestingly, smoking and male patients had a higher prevalence of HPV 16, although not reaching a statistical significance, compared with non-smoking and female patients, respectively (33.3{\%} for smokers versus 20.0{\%} non-smokers; 33.3{\%} for male versus 17.6{\%} for female). As compared with the HPV 16/18 infection in Taiwan, Chinese patients with lung cancer from Wuhan had a different HPV 16/18 infection prevalence. Conclusion: Difference in HPV 16/18 infection in lung cancer patients from Wuhan, China and Taichung, Taiwan suggests that HPV 16/18 might play a different role in lung cancer development among Chinese living in different areas.",
keywords = "Human papillomavirus, Non-small cell lung cancer",
author = "Yang Fei and Jiong Yang and Hsieh, {Wei Chung} and Wu, {Jeng Yuan} and Wu, {Tzu Chin} and Goan, {Yih Gang} and Huei Lee and Cheng, {Ya Wen}",
year = "2006",
month = "5",
doi = "10.1093/jjco/hyl017",
language = "English",
volume = "36",
pages = "274--279",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China

AU - Fei, Yang

AU - Yang, Jiong

AU - Hsieh, Wei Chung

AU - Wu, Jeng Yuan

AU - Wu, Tzu Chin

AU - Goan, Yih Gang

AU - Lee, Huei

AU - Cheng, Ya Wen

PY - 2006/5

Y1 - 2006/5

N2 - Background: Inconsistency in the prevalence of infection by human papillomavirus (HPV) in lung cancer patients was found between different countries with racial and geographic variations. Our previous reports have indicated that a high-risk HPV 16/18 DNA was frequently detected in Chinese lung cancer patients living in Taichung, Taiwan (Cheng et al. Cancer Res. 2001;61:2799-803). Thus, we conducted this study to verify whether there was a similar HPV 16/18 infection prevalence in lung cancer patients from Wuhan, China. Methods: To reduce the false positive HPV detection, the paraffin sections of 73 lung tumors and 34 non-cancer controls from Wuhan, China were collected for detection of the presence of HPV 16/18 DNA by in situ hybridization (ISH). Results: Our results showed that the rates of HPV 16 and/or 18 infections in patients with lung tumors were significantly higher than in 34 non-cancer control subjects (26.0 versus 2.8% for HPV 16, P = 0.030; 23.3 versus 5.7% for HPV 18, P = 0.031; 27.7 versus 5.9% for HPV 16 or 18, P = 0.003) with a similar infection frequency of HPV 16 and 18 types in lung tumors. This result indicated that HPV 16/18 infection may be associated with lung cancer development in Chinese patients from Wuhan, China. Further statistical analyses revealed that HPV 16 or 18 infection was not correlated with any clinico-pathological parameter studied, including age, gender, smoking status, tumor type, tumor stage and tumor grades. Interestingly, smoking and male patients had a higher prevalence of HPV 16, although not reaching a statistical significance, compared with non-smoking and female patients, respectively (33.3% for smokers versus 20.0% non-smokers; 33.3% for male versus 17.6% for female). As compared with the HPV 16/18 infection in Taiwan, Chinese patients with lung cancer from Wuhan had a different HPV 16/18 infection prevalence. Conclusion: Difference in HPV 16/18 infection in lung cancer patients from Wuhan, China and Taichung, Taiwan suggests that HPV 16/18 might play a different role in lung cancer development among Chinese living in different areas.

AB - Background: Inconsistency in the prevalence of infection by human papillomavirus (HPV) in lung cancer patients was found between different countries with racial and geographic variations. Our previous reports have indicated that a high-risk HPV 16/18 DNA was frequently detected in Chinese lung cancer patients living in Taichung, Taiwan (Cheng et al. Cancer Res. 2001;61:2799-803). Thus, we conducted this study to verify whether there was a similar HPV 16/18 infection prevalence in lung cancer patients from Wuhan, China. Methods: To reduce the false positive HPV detection, the paraffin sections of 73 lung tumors and 34 non-cancer controls from Wuhan, China were collected for detection of the presence of HPV 16/18 DNA by in situ hybridization (ISH). Results: Our results showed that the rates of HPV 16 and/or 18 infections in patients with lung tumors were significantly higher than in 34 non-cancer control subjects (26.0 versus 2.8% for HPV 16, P = 0.030; 23.3 versus 5.7% for HPV 18, P = 0.031; 27.7 versus 5.9% for HPV 16 or 18, P = 0.003) with a similar infection frequency of HPV 16 and 18 types in lung tumors. This result indicated that HPV 16/18 infection may be associated with lung cancer development in Chinese patients from Wuhan, China. Further statistical analyses revealed that HPV 16 or 18 infection was not correlated with any clinico-pathological parameter studied, including age, gender, smoking status, tumor type, tumor stage and tumor grades. Interestingly, smoking and male patients had a higher prevalence of HPV 16, although not reaching a statistical significance, compared with non-smoking and female patients, respectively (33.3% for smokers versus 20.0% non-smokers; 33.3% for male versus 17.6% for female). As compared with the HPV 16/18 infection in Taiwan, Chinese patients with lung cancer from Wuhan had a different HPV 16/18 infection prevalence. Conclusion: Difference in HPV 16/18 infection in lung cancer patients from Wuhan, China and Taichung, Taiwan suggests that HPV 16/18 might play a different role in lung cancer development among Chinese living in different areas.

KW - Human papillomavirus

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=33745686435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745686435&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyl017

DO - 10.1093/jjco/hyl017

M3 - Article

C2 - 16690730

AN - SCOPUS:33745686435

VL - 36

SP - 274

EP - 279

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 5

ER -